Authors:
ARTILLO S
PASTORE G
ALBERTI A
MILELLA M
SANTANTONIO T
FATTOVICH G
GIUSTINA G
RYFF JC
CHANEAC M
BARTOLOME J
CARRENO V
Citation: S. Artillo et al., DOUBLE-BLIND, RANDOMIZED CONTROLLED TRIAL OF INTERLEUKIN-2 TREATMENT OF CHRONIC HEPATITIS-B, Journal of medical virology, 54(3), 1998, pp. 167-172
Citation: Jc. Ryff, TREATMENT OF CHRONIC HEPATITIS-C WITH INTERFERON - HOW LONG SHOULD A LASTING RESPONSE LAST IF A LASTING RESPONSE COULD LAST, Journal of viral hepatitis, 4, 1997, pp. 95-99
Citation: H. Schellekens et al., ASSAYS FOR ANTIBODIES TO HUMAN INTERFERON-ALPHA - THE NEED FOR STANDARDIZATION, Journal of interferon & cytokine research, 17, 1997, pp. 5-8
Citation: Jc. Ryff, CLINICAL INVESTIGATION OF THE IMMUNOGENICITY OF INTERFERON-ALPHA-2A, Journal of interferon & cytokine research, 17, 1997, pp. 29-33
Authors:
REDDY R
KRAWITT E
JACOBSON I
ZAKARIJA M
DEPAMPHILIS J
RYFF JC
DREWS H
Citation: R. Reddy et al., THYROID-DYSFUNCTION IN CHRONIC HEPATITIS-C AND FOLLOWING INTERFERON-ALPHA 2A TREATMENT, Hepatology, 26(4), 1997, pp. 960-960
Authors:
NEGRO E
ABATE ML
MONDARDINI A
BALDI M
LEANDRO G
LOMBARDI S
WOLFE L
RYFF JC
VERME G
BRUNETTO MR
BONINO F
Citation: E. Negro et al., THE FLUCTUATIONS OF HEPATITIS-C VIRUS-RNA AND IGM ANTI-HCV (CORE) SERUM LEVELS CORRELATE WITH THOSE OF ALANINE AMINOTRANSFERASES DURING THEHEPATITIS RELAPSES OF PATIENTS TREATED WITH INTERFERON, Journal of viral hepatitis, 2(4), 1995, pp. 171-174
Authors:
THOMAS HC
LOK ASF
CARRENO V
FARRELL G
TANNO H
PEREZ V
DUSHEIKO GM
COOKSLEY G
RYFF JC
Citation: Hc. Thomas et al., COMPARATIVE-STUDY OF 3 DOSES OF INTERFERON-ALPHA-2A IN CHRONIC ACTIVEHEPATITIS-B (VOL 1, PG 139, 1994), Journal of viral hepatitis, 2(1), 1995, pp. 63-63
Authors:
CARRENO V
GERKEN G
TREPO C
BARMEIR S
DESMET V
RYFF JC
Citation: V. Carreno et al., 4 YEARS OF FOLLOW-UP (LTFUP) OF PATIENTS WITH CHRONIC HEPATITIS-C (CHC) TREATED WITH INTERFERON-ALPHA-2A, Hepatology, 22(4), 1995, pp. 268-268
Authors:
GUTEKUNST K
WOLFE L
LOMBARDI S
SMITH P
RYFF JC
Citation: K. Gutekunst et al., PERFORMANCE OF A QUANTITATIVE PCR BASED ASSAY FOR HCV IN CONJUNCTION WITH GENOTYPING OF CHRONIC HCV PATIENTS UNDERGOING ANTIVIRAL THERAPY, Hepatology, 20(4), 1994, pp. 10000244-10000244
Authors:
NEGRO F
BALDI M
MONDARDINI A
LEANDRO G
CHANEAC M
MANZINI P
ABATE ML
ZAHM F
DASTOLI G
BALLARE M
RYFF JC
VERME G
BONINO F
Citation: F. Negro et al., CONTINUOUS VERSUS INTERMITTENT THERAPY FOR CHRONIC HEPATITIS-C WITH RECOMBINANT INTERFERON ALFA-2A, Gastroenterology, 107(2), 1994, pp. 479-485
Authors:
NEGRO F
BALDI M
MONDARDINI A
SCHLEGEL M
CHANEAC M
MANZINI P
ABATE ML
VERME G
RYFF JC
BONINO F
Citation: F. Negro et al., SIGNIFICANCE OF INTERFERON RESISTANCE DEVELOPING IN CHRONIC HEPATITIS-C DURING CONTINUOUS OR PULSE INTERFERON TREATMENT, Hepatology, 18(4), 1993, pp. 10000246-10000246
Citation: Jc. Ryff, TO TREAT OR NOT TO TREAT - THE JUDICIOUS USE OF INTERFERON-ALPHA-2A FOR THE TREATMENT OF CHRONIC HEPATITIS-B, Journal of hepatology, 17, 1993, pp. 42-46
Authors:
HUDSON M
GALLATI H
RYFF JC
POUNDER RE
WAKEFIELD AJ
Citation: M. Hudson et al., SERUM TUMOR-NECROSIS-FACTOR (TNF) AND SOLUBLE TNF RECEPTORS P55 AND P75 IN CROHNS-DISEASE, Gastroenterology, 104(4), 1993, pp. 715-715
Authors:
CHRISTOPHERSEN J
FROM E
KRISTIANSEN F
MOLLER B
BLAAKAER J
GROSS G
GOOS M
IKENBERG H
MENSING H
NEUMANN C
BAUER R
PETZOLDT D
MEIGEL W
WEISSENBACHER E
ALBRECHT G
HOFFMANN H
PETERSEN E
HAGEDORN M
ORFANOS CE
BROKER EM
WASSILEW SW
BONNERANDI JJ
MORRISON GD
SYRJANEN K
SYRJANEN S
WALKER M
RYFF JC
SMITH P
WAHL M
HAMMER R
DREES N
BLACKBURN N
BERGER F
Citation: J. Christophersen et al., RECURRENT CONDYLOMATA ACUMINATA TREATED WITH RECOMBINANT INTERFERON ALPHA-2A - A MULTICENTER DOUBLE-BLIND PLACEBO-CONTROLLED CLINICAL-TRIAL, Acta dermato-venereologica, 73(3), 1993, pp. 223-226